News

September 19, 2019

FDA Approves Erleada to Treat Metastatic Castration-sensitive Prostate Cancer

News

The U.S. Food and Drug Administration (FDA) has approved Erleada (apalutamide) for the treatment of men with metastatic castration-sensitive prostate cancer (mCSPC), or those whose cancer still responds to androgen ... Read more

September 18, 2019

Study Describes New Imaging Technique for Detecting Prostate Cancer

News

A new imaging technique that combines ultrasound and photoacoustic imaging of the prostate delivers detailed information about the prostate’s anatomy and cancer location, identifying some cancers that would be ... Read more

September 16, 2019

PSMA PET-CT Offers Better Detection Rates in Recurrent PC, Study Says

News

The imaging agent 68Ga-PSMA-11 has better detection rates than 18F-fluciclovine in men with recurrent prostate cancer who have already had radical surgery to remove the prostate and whose levels ... Read more

September 12, 2019

Landmarks Lit in Blue in Every US State to Launch Prostate Cancer Awareness Month

News

For the first time, landmarks in all 50 U.S. states were illuminated in blue on Sept. 3 to launch Prostate Cancer Awareness Month. The Prostate Cancer Foundation‘s “Light It ... Read more

September 11, 2019

Largest-ever African American Prostate Cancer Study Seeks Participants

News

African American men recently diagnosed with prostate cancer are being recruited across the U.S. for the largest-ever prostate cancer study in this ethnic group. The study is a joint effort ... Read more

September 9, 2019

Provenge Extends Survival of mCRPC Patients By Up to 4 Years, Data Show

News

Treatment with the immunotherapy Provenge (sipuleucel-T) in a real-world setting is showing similar safety and efficacy in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC) as ... Read more

September 5, 2019

Collaborators Work to Develop New Sequencing Methods to Manage Cancers

News

The nonprofit organization Genome Canada, the pharmaceutical company Thermo Fisher Scientific and the Ontario Institute for Cancer Research (OICR) are collaborating to develop new targeted next generation sequencing (NGS) ... Read more

September 4, 2019

Add-on Onvansertib Overcomes Resistance to Zytiga in mCRPC, Early Data Show

News

Adding the investigational oral therapy onvansertib to a regimen of Zytiga (abiraterone acetate) and prednisone overcomes resistance to Zytiga in men with metastatic castration-resistant prostate cancer (mCRPC), according to ... Read more

August 29, 2019

FDA Clears Way for Trial of Immunotherapy in Advanced Prostate Cancer, Scripps Research Says

News

The U.S. Food and Drug Administration (FDA) has signed off on a clinical trial that will test CCW702, an immunotherapy developed by Calibr at Scripps Research, as a possible treatment ... Read more

August 28, 2019

Telix Enters Collaboration with DKFZ Researchers to Develop Image-Guided Surgery

News

Telix Pharmaceuticals has established a collaboration agreement with a team of researchers from the German Cancer Research Center (Deutsches Krebsforschungszentrum, or DKFZ) to develop an innovative image-guided surgery for ... Read more

Pin It on Pinterest